Lung cancer is the leading cause of cancer-related deaths in the United States. Filling a gap in the literature, this resource translates recent laboratory findings into practical applications for the prevention and control of lung cancer.
Featuring chapters by seasoned researchers in the field, this reference reviews current advances in imaging, drug development, molecular therapeutics, genetics, immunotherapy, and chemotherapy, to stand at the forefront of technologies for patient diagnosis and treatment.
Key Features:
- Acquainting specialists with recent progress in the development of new and effective therapies for disease control, this sourcereviews the scientific principles, trial results, and clinical implications of emerging and translational therapies
- prognostic/predictive markers for lung cancer
- enables clinicians to select and utilize new therapies to optimize patient outcomes
- conveniently synthesizes emerging therapies such as antiangiogensis and EGFR inhibitors, tumor vaccines, monoclonal antibodies, endothelial receptor antagonists, and combination therapies involving already established treatments into one all-inclusive
- volume
- identifies current and future targets of therapy, trial design, and patient selection
